<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="rapid-communication" dtd-version="2.3">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">molbank</journal-id>
      <journal-title>Molbank</journal-title>
      <abbrev-journal-title abbrev-type="publisher">Molbank</abbrev-journal-title>
      <abbrev-journal-title abbrev-type="pubmed">Molbank</abbrev-journal-title>
      <issn pub-type="epub">1422-8599</issn>
      <publisher>
        <publisher-name>MDPI</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3390/M894</article-id>
      <article-id pub-id-type="publisher-id">molbank-2016-M894</article-id>
      <article-categories>
        <subj-group>
          <subject>Short Note</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>1-[2-(4-Methyl-7-coumarinyloxy)ethyl]-4-(5-{1-[2-(4-methyl-7-coumarinyloxy)ethyl]-1<italic>H</italic>-1,2,3-triazol-4-yl}pentyl)-1<italic>H</italic>-1,2,3-triazole</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Torres</surname>
            <given-names>Fernando Cidade</given-names>
          </name>
          <xref rid="af1-molbank-2016-M894" ref-type="aff">1</xref>
          <xref rid="af2-molbank-2016-M894" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>de Azambuja</surname>
            <given-names>Gabriel Oliveira</given-names>
          </name>
          <xref rid="af1-molbank-2016-M894" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gon&#xE7;alves</surname>
            <given-names>Itamar Lu&#xED;s</given-names>
          </name>
          <xref rid="af1-molbank-2016-M894" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gon&#xE7;alves</surname>
            <given-names>Guilherme Arrach&#xE9;</given-names>
          </name>
          <xref rid="af1-molbank-2016-M894" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>von Poser</surname>
            <given-names>Gilsane Lino</given-names>
          </name>
          <xref rid="af1-molbank-2016-M894" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kawano</surname>
            <given-names>Daniel F&#xE1;bio</given-names>
          </name>
          <xref rid="af3-molbank-2016-M894" ref-type="aff">3</xref>
          <xref rid="af4-molbank-2016-M894" ref-type="aff">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Eifler-Lima</surname>
            <given-names>Vera Lucia</given-names>
          </name>
          <xref rid="af1-molbank-2016-M894" ref-type="aff">1</xref>
          <xref rid="c1-molbank-2016-M894" ref-type="corresp">*</xref>
        </contrib>
        <contrib contrib-type="editor">
          <name>
            <surname>Haider</surname>
            <given-names>Norbert</given-names>
          </name>
          <role>Academic Editor</role>
        </contrib>
      </contrib-group>
      <aff id="af1-molbank-2016-M894"><label>1</label>Faculdade de Farm&#xE1;cia, Universidade Federal do Rio Grande do Sul, Av. Ipiranga 2752, 90610-000 Porto Alegre-RS, Brazil; <email>fernando_torres@uniritter.edu.br</email> (F.C.T.); <email>gabriel_azambuja90@hotmail.com</email> (G.O.d.A.); <email>itamar3141@yahoo.com.br</email> (I.L.G.); <email>guiarrache@gmail.com</email> (G.A.G.); <email>gilsane.von@ufrgs.br</email> (G.L.v.P.)</aff>
      <aff id="af2-molbank-2016-M894"><label>2</label>Faculdade de Farm&#xE1;cia, Centro Universit&#xE1;rio Ritter dos Reis, Rua Orfanotr&#xF3;fio 55, 91849-440 Porto Alegre-RS, Brazil</aff>
      <aff id="af3-molbank-2016-M894"><label>3</label>Faculdade de Ci&#xEA;ncias Farmac&#xEA;uticas, Universidade Estadual de Campinas, Rua S&#xE9;rgio Buarque de Holanda 250, 13083-859 Campinas-SP, Brazil; <email>dkawano@unicamp.br</email></aff>
      <aff id="af4-molbank-2016-M894"><label>4</label>Departamento de Qu&#xED;mica Org&#xE2;nica, Instituto de Qu&#xED;mica, Universidade Estadual de Campinas, Rua Josu&#xE9; de Castro s/n, 13083-970 Campinas-SP, Brazil</aff>
      <author-notes>
        <corresp id="c1-molbank-2016-M894"><label>*</label> Correspondence: <email>veraeifler@ufrgs.br</email>; Tel.: +55-51-3308-5362</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>11</day>
        <month>04</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>06</month>
        <year>2016</year>
      </pub-date>
      <volume>2016</volume>
      <issue>2</issue>
      <elocation-id>M894</elocation-id>
      <history>
        <date date-type="received">
          <day>08</day>
          <month>02</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>31</day>
          <month>03</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2016 by the authors; licensee MDPI, Basel, Switzerland.</copyright-statement>
        <copyright-year>2016</copyright-year>
        <license>
          <p>This article is an open access article distributed under the terms and conditions of the Creative Commons by Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).</p>
        </license>
      </permissions>
      <abstract>
        <p>Nature often produces compounds with a high degree of symmetry to reduce structural information and complexity. Synthesis of identical twin drugs, through the linkage of two identical pharmacophoric entities, is a classical strategy to produce more potent and/or selective drugs. Herein, two units of the privileged core of the coumarin hymecromone were linked together using &#x201C;click chemistry&#x201D;. Synthesis of 1-[2-(4-Methyl-7-coumarinyloxy)ethyl]-4-(5-{1-[2-(4-methyl-7-coumarinyloxy)ethyl]-1<italic>H</italic>-1,2,3-triazol-4-yl}pentyl)-1<italic>H</italic>-1,2,3-triazole was achieved by coupling of two identical units of an azido coumarin with a symmetrical alkine using copper(I)-catalyzed alkyne-azide cycloaddition reaction, in good yields and with complete regioselectivity.</p>
      </abstract>
      <kwd-group>
        <kwd>coumarins</kwd>
        <kwd>twin drugs</kwd>
        <kwd>click chemistry</kwd>
        <kwd>pechmann condensation</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="sec1-molbank-2016-M894" sec-type="intro">
      <title>1. Introduction</title>
      <p>Aiming to reduce structural information and complexity, nature often produces compounds with a high degree of symmetry, as observed for the macromolecules HIV protease, hemoglobin and insulin. The linkage of two identical pharmacophoric entities, generating an &#x201C;identical twin drug&#x201D; or homodimer derivative, is a classical strategy used in medicinal chemistry to produce more potent and/or selective drugs compared to the single entities. These new compounds will have specific pharmacokinetic and pharmacodynamic properties, which normally differ from what it would be expected by simple doubling the dose of the drug [<xref ref-type="bibr" rid="B1-molbank-2016-M894">1</xref>].</p>
      <p>Coumarins are a large class of compounds that display a wide variety of interesting biological properties [<xref ref-type="bibr" rid="B2-molbank-2016-M894">2</xref>,<xref ref-type="bibr" rid="B3-molbank-2016-M894">3</xref>,<xref ref-type="bibr" rid="B4-molbank-2016-M894">4</xref>,<xref ref-type="bibr" rid="B5-molbank-2016-M894">5</xref>,<xref ref-type="bibr" rid="B6-molbank-2016-M894">6</xref>,<xref ref-type="bibr" rid="B7-molbank-2016-M894">7</xref>], being their 2<italic>H</italic>-chromen-2-one nuclei the structural feature responsible for this &#x201C;privileged&#x201D; pharmacological profile. This planar ring system is composed by one aromatic ring, capable of establishing hydrophobic, &#x3C0;-&#x3C0;, CH-&#x3C0; and cation-&#x3C0; interactions, and one lactone ring, which contains two oxygen atoms that may interact via hydrogen bonding with a series of amino acid residues, such as serine, threonine, cysteine, asparagine, glutamine, and tyrosine [<xref ref-type="bibr" rid="B8-molbank-2016-M894">8</xref>].</p>
      <p>In order to explore the possibility of potency and selectivity enhancements provided by the synthesis of twin drugs, two units of the privileged 2<italic>H</italic>-chromen-2-one nuclei of hymecromone (7-hydroxy-4-methylcoumarin) were linked together using &#x201C;click chemistry&#x201D;, a set of highly efficient conjugation reactions commonly used to join two or more entities [<xref ref-type="bibr" rid="B9-molbank-2016-M894">9</xref>].</p>
    </sec>
    <sec id="sec2-molbank-2016-M894">
      <title>2. Experimental Section</title>
      <sec id="sec2dot1-molbank-2016-M894">
        <title>2.1. General Information</title>
        <p>All chemicals were purchased as reagent grade and used without further purification. Solvents were distilled and/or dried according to standard methods [11]. Column chromatography was performed on silica gel 60 (0.040&#x2013;0.063 mm) using CH<sub>2</sub>Cl<sub>2</sub> and CH<sub>2</sub>Cl<sub>2</sub>/EtOAc (5:1 v/v or 2:1 v/v). Microwave-assisted reactions were performed on a CEM Discover<sup>&#xAE;</sup> Microwave System. Melting points were determined on a Fisatom 431 apparatus, which were uncorrected. MS spectra were recorded on Q-Tof micro Waters high resolution mass spectrometer, operating in electrospray ionization mode. Nuclear magnetic resonance spectra were recorded on Bruker Advance DPX 400 (400 MHz) spectrometer. Chemical shifts (&#x3B4;) are given in parts per million downfield from tetramethylsilane. 7-(2-Azidoethoxy)-4-methyl-2<italic>H</italic>-chromen-2-one (<bold>1</bold>) was synthesized according to reported methods [<xref ref-type="bibr" rid="B10-molbank-2016-M894">10</xref>] and coupled with commercial 1,8-nonadiyne (<bold>2</bold>) by using the copper(I)-catalyzed alkyne-azide cycloaddition reaction, in good yields and with complete regioselectivity (<xref ref-type="scheme" rid="molbank-2016-M894-sch001">Scheme 1</xref>).</p>
      </sec>
      <sec id="sec2dot2-molbank-2016-M894">
        <title>2.2. Synthesis of 1-[2-(4-Methyl-7-coumarinyloxy)ethyl]-4-(5-{1-[2-(4-methyl-7-coumarinyloxy)ethyl]-1H-1,2,3-triazol-4-yl}pentyl)-1H-1,2,3-triazole <italic>(<bold>3</bold>)</italic></title>
        <p>1,8-nonadiyne (<bold>2</bold>) (0.15 mL, 1.1 equiv) was added to a solution of <bold>1</bold> in DMF (0.5&#x2013;1 M, 0.1 mL) in a microwave flask (0.2 mL) equipped with a stirring bar. Sodium ascorbate (0.1 equiv) and CuSO<sub>4</sub> (0.03 equiv) were added, the tube was sealed, and the mixture was stirred for 25 seconds at room temperature, followed by heating under microwave irradiation at 70 &#xB0;C (18 W) in 2 cycles of 20 min. Consumption of the reactant was followed by TLC (CH<sub>2</sub>Cl<sub>2</sub>/EtOAc 2:1 v/v). The reaction mixture was partitioned between H<sub>2</sub>O and EtOAc, the aqueous phase was extracted with EtOAc three times. The organic phase was dried over MgSO<sub>4</sub>, filtered, concentrated, and the residue purified by column chromatography with a CH<sub>2</sub>Cl<sub>2</sub>/EtOAc gradient [<xref ref-type="bibr" rid="B10-molbank-2016-M894">10</xref>]. Yield 67%; mp 168 &#xB0;C; <sup>1</sup>H NMR (400 MHz, DMSO-<italic>d</italic><sub>6</sub>) <italic>&#x3B4;</italic> 7.90 (s, 2H), 7.64 (d, 2H, <italic>J</italic> 8.8 Hz), 6.96 (d, 2H, <italic>J</italic> 2.6 Hz), 6.91 (dd, 2H, <italic>J</italic> 8.8, 2.6 Hz), 6.19 (d, 2H, <italic>J</italic> 1.2 Hz), 4.73 (t, 4H, <italic>J</italic> 5.0 Hz), 4.50 (t, 4H, <italic>J</italic> 5.0 Hz), 2.57 (t, 4H, <italic>J</italic> 7.6 Hz), 2.36 (d, 6H, <italic>J</italic> 1.2 Hz), 1.57 (quint, 4H, <italic>J</italic> 7.6 Hz), 1.31 (quint, 2H, <italic>J</italic> 7.6 Hz); <sup>13</sup>C NMR (100 MHz, DMSO-<italic>d</italic><sub>6</sub>) <italic>&#x3B4;</italic> 160.9, 160.1, 154.6, 153.4, 146.9, 126.5, 122.4, 113.5, 112.5, 111.4, 101.4, 66.9, 48.7, 28.7, 28.1, 24.9, 18.1; HRMS (ESI) <italic>m/z</italic>, calcd. for C<sub>33</sub>H<sub>35</sub>N<sub>6</sub>O<sub>6</sub> [M + H]<sup>+</sup>: 611.2573, found: 611.3377.</p>
      </sec>
    </sec>
  </body>
  <back>
  <app-group>
    <app id="app1-molbank-2016-M894">
      <title>Supplementary Materials</title>
      <p><sup>1</sup>H, <sup>13</sup>C-NMR and HRMS spectra for compound <bold>3</bold> and the molfiles can be found at <uri>http://www.mdpi.com/1422-8599/2016/2/M894</uri>.</p>
    </app>
    </app-group>
    <ack>
      <title>Acknowledgments</title>
      <p>The authors thank the Brazilian funding agencies CAPES (Coordena&#xE7;&#xE3;o de Aperfei&#xE7;oamento de Pessoal de N&#xED;vel Superior), CNPq (Conselho Nacional de Desenvolvimento Cient&#xED;fico e Tecnol&#xF3;gico), FAPERGS (Funda&#xE7;&#xE3;o de Amparo &#xE0; Pesquisa do Estado do Rio Grande do Sul), FAPESP (Funda&#xE7;&#xE3;o de Amparo &#xE0; Pesquisa do Estado de S&#xE3;o Paulo), and Instituto Nacional de Ci&#xEA;ncia e Tecnologia para Inova&#xE7;&#xE3;o Farmac&#xEA;utica (INCT-IF) for the financial support. The authors are thankful to Prof. Saulo Fernandes de Andrade (PPGCF/UFRGS) and Prof. Francisco Paulo dos Santos (IQ/UFRGS) for the support on the NMR analyses and to Maristela Cabral da Silva Piedade (LaSOM/UFRGS) and Maribete Homrich Holzschuh (PPGCF/UFRGS) for the technical support.</p>
    </ack>
    <notes>
      <title>Author Contributions</title>
      <p>Fernando Torres, Gabriel Azambuja, Itamar Gon&#xE7;alves and Guilherme Gon&#xE7;alves: experimental work; Gilsane von Poser, Daniel Kawano and Vera Eifler: literature search, design of the synthesis and writing of the paper.</p>
    </notes>
    <notes>
      <title>Conflicts of Interest</title>
      <p>The authors declare no conflict of interest.</p>
    </notes>
    <ref-list>
      <title>References</title>
      <ref id="B1-molbank-2016-M894">
        <label>1.</label>
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Contreras</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Sippl</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <article-title>Homo and heterodimer ligands: The twin drug approach</article-title>
          <source>The Practice of Medicinal Chemistry</source>
          <edition>3nd ed.</edition>
          <person-group person-group-type="editor">
            <name>
              <surname>Wermuth</surname>
              <given-names>C.G.</given-names>
            </name>
          </person-group>
          <publisher-name>Academic Press</publisher-name>
          <publisher-loc>London, UK</publisher-loc>
          <year>2008</year>
          <fpage>380</fpage>
          <lpage>414</lpage>
        </citation>
      </ref>
      <ref id="B2-molbank-2016-M894">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>G&#xF3;mez-Outes</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Su&#xE1;rez-Gea</surname>
              <given-names>M.L.</given-names>
            </name>
            <name>
              <surname>Calvo-Rojas</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Lecumberri</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Rocha</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Pozo-Hern&#xE1;ndez</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Terleira-Fern&#xE1;ndez</surname>
              <given-names>A.I.</given-names>
            </name>
            <name>
              <surname>Vargas-Castrill&#xF3;n</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Discovery of anticoagulant drugs: A historical perspective</article-title>
          <source>Curr. Drug Discov. Technol.</source>
          <year>2012</year>
          <volume>9</volume>
          <fpage>83</fpage>
          <lpage>104</lpage>
          <pub-id pub-id-type="doi">10.2174/1570163811209020083</pub-id>
          <pub-id pub-id-type="pmid">21838662</pub-id>
        </citation>
      </ref>
      <ref id="B3-molbank-2016-M894">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Matos</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Vi&#xF1;a</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Vazquez-Rodriguez</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Uriarte</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Santana</surname>
              <given-names>L.</given-names>
            </name>
          </person-group>
          <article-title>Focusing on new monoamine oxidase inhibitors: Differently substituted coumarins as an interesting scaffold</article-title>
          <source>Curr. Top. Med. Chem.</source>
          <year>2012</year>
          <volume>12</volume>
          <fpage>2210</fpage>
          <lpage>2239</lpage>
          <pub-id pub-id-type="doi">10.2174/156802612805220002</pub-id>
          <pub-id pub-id-type="pmid">23231397</pub-id>
        </citation>
      </ref>
      <ref id="B4-molbank-2016-M894">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vianna</surname>
              <given-names>D.R.</given-names>
            </name>
            <name>
              <surname>Bubols</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Meirelles</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Silva</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Rocha</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Lanznaster</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Monserrat</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>Garcia</surname>
              <given-names>S.C.</given-names>
            </name>
            <name>
              <surname>von Poser</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Eifler-Lima</surname>
              <given-names>V.L.</given-names>
            </name>
          </person-group>
          <article-title>Evaluation of the antioxidant capacity of synthesized coumarins</article-title>
          <source>Int. J. Mol. Sci.</source>
          <year>2012</year>
          <volume>13</volume>
          <fpage>7260</fpage>
          <lpage>7270</lpage>
          <pub-id pub-id-type="doi">10.3390/ijms13067260</pub-id>
          <pub-id pub-id-type="pmid">22837692</pub-id>
        </citation>
      </ref>
      <ref id="B5-molbank-2016-M894">
        <label>5.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vianna</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Hamerski</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Figueir&#xF3;</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Bernardi</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Visentin</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Teixeira</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Pires</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Eifler-Lima</surname>
              <given-names>V.L.</given-names>
            </name>
            <name>
              <surname>Salbego</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Batasttini</surname>
              <given-names>A.M.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Selective cytotoxicity and apoptosis induction in glioma cell lines by 5-oxygenated-6,7-methylenedioxycoumarins from <italic>Pterocaulon</italic> species</article-title>
          <source>Eur. J. Med. Chem.</source>
          <year>2012</year>
          <volume>57</volume>
          <fpage>268</fpage>
          <lpage>274</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejmech.2012.09.007</pub-id>
          <pub-id pub-id-type="pmid">23069682</pub-id>
        </citation>
      </ref>
      <ref id="B6-molbank-2016-M894">
        <label>6.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vianna</surname>
              <given-names>D.R.</given-names>
            </name>
            <name>
              <surname>Ruschel</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Dietrich</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Figueir&#xF3;</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Morrone</surname>
              <given-names>F.B.</given-names>
            </name>
            <name>
              <surname>Canto</surname>
              <given-names>R.F.S.</given-names>
            </name>
            <name>
              <surname>Corvello</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Velho</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Crestani</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Teixeira</surname>
              <given-names>H.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>4-Methylcoumarins with cytotoxic activity against T24 and RT4 human bladder c&#xE2;ncer cell lines</article-title>
          <source>MedChemComm</source>
          <year>2015</year>
          <volume>6</volume>
          <fpage>905</fpage>
          <lpage>911</lpage>
          <pub-id pub-id-type="doi">10.1039/C5MD00039D</pub-id>
        </citation>
      </ref>
      <ref id="B7-molbank-2016-M894">
        <label>7.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Matos</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Vazquez-Rodriguez</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Santana</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Uriarte</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Fuentes-Edfuf</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Santos</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Mu&#xF1;oz-Crego</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Looking for new targets: Simple coumarins as antibacterial agents</article-title>
          <source>Med. Chem.</source>
          <year>2012</year>
          <volume>8</volume>
          <fpage>1140</fpage>
          <lpage>1145</lpage>
          <pub-id pub-id-type="pmid">22779756</pub-id>
        </citation>
      </ref>
      <ref id="B8-molbank-2016-M894">
        <label>8.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Torres</surname>
              <given-names>F.C.</given-names>
            </name>
            <name>
              <surname>Brucker</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Andrade</surname>
              <given-names>S.F.</given-names>
            </name>
            <name>
              <surname>Kawano</surname>
              <given-names>D.F.</given-names>
            </name>
            <name>
              <surname>Garcia</surname>
              <given-names>S.C.</given-names>
            </name>
            <name>
              <surname>Poser</surname>
              <given-names>G.L.V.</given-names>
            </name>
            <name>
              <surname>Eifler-Lima</surname>
              <given-names>V.L.</given-names>
            </name>
          </person-group>
          <article-title>New insights into the chemistry and antioxidant activity of coumarins</article-title>
          <source>Curr. Top. Med. Chem.</source>
          <year>2014</year>
          <volume>14</volume>
          <fpage>2600</fpage>
          <lpage>2623</lpage>
          <pub-id pub-id-type="doi">10.2174/1568026614666141203144551</pub-id>
          <pub-id pub-id-type="pmid">25478878</pub-id>
        </citation>
      </ref>
      <ref id="B9-molbank-2016-M894">
        <label>9.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Arag&#xE3;o-Leoneti</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Campo</surname>
              <given-names>V.L.</given-names>
            </name>
            <name>
              <surname>Gome</surname>
              <given-names>A.S.</given-names>
            </name>
            <name>
              <surname>Field</surname>
              <given-names>R.A.</given-names>
            </name>
            <name>
              <surname>Carvalho</surname>
              <given-names>I.</given-names>
            </name>
          </person-group>
          <article-title>Application of copper(I)-catalysed azide/alkyne cycloaddition (CuAAC) &#x201C;click chemistry&#x201D; in carbohydrate drug and neoglycopolymer synthesis</article-title>
          <source>Tetrahedron</source>
          <year>2010</year>
          <volume>66</volume>
          <fpage>9475</fpage>
          <lpage>9492</lpage>
          <pub-id pub-id-type="doi">10.1016/j.tet.2010.10.001</pub-id>
        </citation>
      </ref>
      <ref id="B10-molbank-2016-M894">
        <label>10.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Torres</surname>
              <given-names>F.C.</given-names>
            </name>
            <name>
              <surname>Goncalves</surname>
              <given-names>G.A.</given-names>
            </name>
            <name>
              <surname>Vanzolini</surname>
              <given-names>K.L.</given-names>
            </name>
            <name>
              <surname>Merlo</surname>
              <given-names>A.A.</given-names>
            </name>
            <name>
              <surname>Gauer</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Garcia</surname>
              <given-names>S.C.</given-names>
            </name>
            <name>
              <surname>Carvalho</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Poser</surname>
              <given-names>G.L.V.</given-names>
            </name>
            <name>
              <surname>Kawano</surname>
              <given-names>D.F.</given-names>
            </name>
            <name>
              <surname>Eifler-Lima</surname>
              <given-names>V.L.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Combining the pharmacophore features of coumarins and 1,4-substituted 1,2,3-triazoles to design new acetylcholinesterase inhibitors: Fast and easy generation of 4-methylcoumarins/1,2,3-triazoles conjugates via click chemistry</article-title>
          <source>J. Braz. Chem. Soc.</source>
          <year>2016</year>
		  <comment>in press</comment>
          <comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://dx.doi.org/10.5935/0103-5053.20160033" ext-link-type="uri">http://dx.doi.org/10.5935/0103-5053.20160033</ext-link></comment>
          <access-date>(accessed on 8 February 2016)</access-date>
        </citation>
      </ref>
	  <ref id="B11-molbank-2016-M894">
        <label>11.</label>
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Armarego</surname>
              <given-names>W.L.F.</given-names>
            </name>
            <name>
              <surname>Chai</surname>
              <given-names>C.L.L.</given-names>
            </name>
          </person-group>
          <source>Purification of Laboratory Chemicals</source>
          <edition>5th ed.</edition>
          <publisher-name>Butterworth-Heinemann</publisher-name>
          <publisher-loc>Burlington, VT, USA</publisher-loc>
          <year>2003</year>
        </citation>
      </ref>
    </ref-list>
    <sec sec-type="display-objects">
      <title>Scheme</title>
      <fig id="molbank-2016-M894-sch001" position="float">
        <object-id pub-id-type="pii">molbank-2016-M894-sch001_Scheme 1</object-id>
        <label>Scheme 1</label>
        <caption>
          <p>Synthesis of 1-[2-(4-Methyl-7-coumarinyloxy)ethyl]-4-(5-{1-[2-(4-methyl-7-coumarinyloxy)ethyl]-1<italic>H</italic>-1,2,3-triazol-4-yl}pentyl)-1<italic>H</italic>-1,2,3-triazole. Reagents, conditions and yields: (a) CuSO<sub>4</sub>, sodium ascorbate, DMF, MW 70 &#xB0;C (18 W), 40 min (67%).</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2016-M894-sch001.tif"/>
      </fig>
    </sec>
  </back>
</article>
